扩张性心肌病变的病理生理学:从机制到精准医学
Marta Gigli1, Davide Stolfo1,2, Marco Merlo1
1Cardiothoracovascular Department, Centre for Diagnosis and Treatment of Cardiomyopathies, European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, Trieste, Italy.
Nature reviews. Cardiology
|October 11, 2024
概括
扩张性心肌病 (DCM) 是一种复杂的心脏疾病,具有遗传和环境原因. 了解这些因素对于开发精准医学和心力衰竭的新疗法至关重要.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 病理生理学 病理生理学
背景情况:
- 扩张性心肌病 (DCM) 是心力衰竭和过早死亡的主要原因.
- 目前的治疗方法集中在心力衰竭和减少喷射率,但精确医学正在出现.
- DCM的发病包括遗传因素,非遗传触发因素及其复杂的相互作用.
研究的目的:
- 审查DCM的病理生理机制.
- 探索从单一的原因到基因与环境相互作用的频谱 ("双击"假说).
- 讨论常见遗传变异和基因修饰剂的作用.
主要方法:
- 关于DCM病理生理学的文献综述.
- 对遗传因果关系和基因型-表型相关性的分析.
- 检查环境因素及其与遗传背景的相互作用.
主要成果:
- DCM的结果来自不同的机制,包括单一的原因和基因环境相互作用.
- 遗传背景显著影响疾病的发病和进展,通常与环境因素结合.
- 常见的遗传变异和基因修饰剂在DCM发展中起作用.
结论:
- 精准医学方法对于个性化DCM治疗至关重要.
- 未来的研究应该专注于小分子,RNA和基因疗法等新疗法.
- 在DCM患者中预防心律失常死亡需要进一步调查.
相关概念视频
Cardiomyopathy V: Interprofessional Care
2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Cardiomyopathy I: Introduction and Classification
2
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
2
Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3


